Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
VOL 2 No. 5 Full Issue - May 2000
1
x
$
20.00
Euprolactinemic Gynecomastia and Galactorrhea with Risperidone-Fluvoxamine Combination by Samir Kumar Praharaj
1
x
$
30.00
Association Between Symptom Severity and Medication Adherence in Adolescents with Bipolar Disorder Demonstrating Suboptimal Adherence
1
x
$
30.00
VOL 2 No. 7 Full Issue - July 2000
1
x
$
20.00
Quetiapine XR Randomized, Double-Blind Study by Arifulla Khan
1
x
$
30.00
Donald S. Robinson, MD: Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials
1
x
$
30.00
Optimizing Treatment Outcomes for Patients With Depression and Generalized Anxiety Disorder
1
x
$
30.00
View Cart
Checkout
Home
Late-Life Anxiety Disorders
“Optimizing Treatment Outcomes for Patients With Depression and Generalized Anxiety Disorder” has been added to your cart.
View cart
Late-Life Anxiety Disorders
$
30.00
Late-Life Anxiety Disorders
By Carl Salzman, MD
Late-Life Anxiety Disorders quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Category:
VOL 38 Supplement No. 1
Tags:
antidepressants
,
anxiety-disorders
,
anxiolytics
,
atypical-antipsychotics
,
carl-salzman
,
elderly
Description
Description
Late-Life Anxiety Disorders
By Carl Salzman, MD
025-30_otsuka_Salzman.qxd_-1
Related products
New Developments in the Neurobiological Basis of Anxiety Disorders
$
30.00
Add to cart
Details
Are SNRIs More Effective than SSRIs? A Review of the Current State of the Controversy
$
30.00
Add to cart
Details
Rebecca Kornbluh, MD: A Survey of Prescribing Preferences in the Treatment of Refractory Depression: Recent Trends
$
30.00
Add to cart
Details
Efficacy of Duloxetine for the Treatment of Depression: Relationship to Most Recent Antidepressant Trial
$
30.00
Add to cart
Details
Page load link
Go to Top
